1-3 of 3
Emily Heath
Close
Sort by
Journal Articles

Patients Who Are Refractory to Ida-FLAG As Initial Induction Chemotherapy for AML Have Persistence of the Dominant Genetic Mutations and a Poor Clinical Outcome

Simon Kavanagh, Emily Heath, Rose Hurren, BSc, Samir H. Barghout, BSPharm, MSc, Sanduni U. Liyanage, Hon. B. Sc, PhD, Thirushi Siriwardena, Jaime Claudio, Tong Zhang, Mahadeo Sukhai, Tracy L. Stockley, Suzanne Kamel-Reid, Amr Rostom, MD, Dina Khalaf, BSc, MSc, MD, Andrzej Lutynski, Anna Rydlewski, MD, Andre C. Schuh, MD FRCPC, Vikas Gupta, MD PhD, Hassan Sibai, MBBS, Dawn Maze, MD FRCPC, MSc, Steven M. Chan, MDPhD, Aaron D. Schimmer, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2596.
https://doi.org/10.1182/blood.V130.Suppl_1.2596.2596
Published: 2017
Journal Articles

Suspicious, Non-MDS-Diagnostic Bone Marrows Have a High Incidence of Clonal Hematopoiesis (CHIP), with MDS-like Clone Size but Restricted Mutation Burden

Brooke Snetsinger, MSc, Emily Heath, BSc, Michael J. Rauh, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1668.
https://doi.org/10.1182/blood.V126.23.1668.1668
Published: 2015
Journal Articles

Tonsillar CD38 + Activated B Cell Fraction Harbours the Highest EBV Load in Patients with Infectious Mononucleosis.

Sridhar Chaganti, Andrew Bell, Emily Heath, Wolfgang Bergler, Michael Kuo, Jane Starczynski, Zbigniew Rudzki, Alan Rickinson
Journal: Blood
Blood (2007) 110 (11): 2277.
https://doi.org/10.1182/blood.V110.11.2277.2277
Published: 2007